Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS)

Launched by ARONPHARMA SP. Z O. O. · Aug 7, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a combination of natural supplements, including polyphenol-rich extracts, prebiotics, and hydrolyzed fiber, can help improve the quality of life for people with Irritable Bowel Syndrome (IBS). The goal is to see if these supplements can reduce IBS symptoms and positively impact markers related to gut health and inflammation.

To participate in this study, individuals must be between 18 and 55 years old and have a diagnosis of IBS. They should also be willing to sign a consent form. However, those currently taking certain supplements or medications, involved in another research study, or with specific health conditions like cancer or severe liver disease cannot join. Participants will receive either the study supplements or a placebo (a non-active version) and will be monitored for their symptoms and overall health. This trial is currently recruiting, so if you or someone you know fits the criteria, it might be a good opportunity to help improve IBS treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed Irritable Bowel Syndrome.
• • Women and men, 18-55 years old.
• • Signed informed consent.
• Exclusion Criteria:
• • Intake of supplements containing plant extracts, polyphenols or anthocyanins, and supplements containing fiber, probiotics and prebiotics.
• • Participation in another clinical trial.
• • Inability to swallow an oral study drug/placebo.
• • Oncological disease, autoimmune disease, severe liver dysfunction, tuberculosis, leukemia, multiple sclerosis, AIDS, rheumatoid arthritis, organ transplant and other gastrointestinal diseases that may affect the results of the study.
• • Women who are pregnant, planning to become pregnant during the study, or breastfeeding,